Marker Therapeutics, Inc.
- MRKR
- NASDAQ
- Biotechnology
- T-Cell Immunotherapies
- Cancer Vaccines
$1.04
Today +13.04%Quote Oct 16, 2026, 08:00 PM UTC
−11.86%over the last month
Max drawdown −28.2%From 1-month high −16.1%3 months −18.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$17.3M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.02
1.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MRKRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5
Founded
1999